| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |